Literature DB >> 7690735

Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.

C Hage1, C L Willman, B E Favara, P G Isaacson.   

Abstract

The immunophenotype and proliferation fraction have been investigated in 26 cases of Langerhans' cell histiocytosis (LCH). In all cases LCH cells were positive for S-100 protein, CD1a, or both. In most cases LCH cells expressed the macrophage-associated marker CD68 and in two cases they contained lysozyme. Expression of both cytoplasmic CD2 and CD3 was observed in cryostat sections. An unexpected finding was the presence of placental alkaline phosphatase in LCH cells. Langerhans' cells in normal skin were negative for both CD2 and CD3, but a proportion contained placental alkaline phosphatase. In four cases of Rosai-Dorfman disease the histiocytic cells, which share certain immunophenotypic properties with Langerhans' cells, also were positive for placental alkaline phosphatase. A significant proportion of LCH cells stained positively with the antibody to proliferating cell nuclear antigen and also with the proliferation marker Ki-S1. A good correlation between the percentage of Ki-67-positive and proliferating cell nuclear antigen- and Ki-S1-positive cells, respectively, was observed. Thus, in comparison with their putative precursors, LCH cells have an aberrant phenotype and are proliferating locally. This might suggest that LCH is a neoplastic rather than a reactive process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690735     DOI: 10.1016/0046-8177(93)90133-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  18 in total

1.  Primary Langerhans Cell Histiocytosis of the Extrahepatic Bile Duct Occurring in an Adult Patient

Authors:  Ifeyinwa E. Obiorah; Alicia Henao Velasquez; Bhaskar Kallakury; Metin Özdemirli
Journal:  Balkan Med J       Date:  2018-03-08       Impact factor: 2.021

2.  Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells.

Authors:  E Brabencova; A Tazi; M Lorenzato; M Bonay; M Kambouchner; J F Emile; A J Hance; P Soler
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 3.  [Diagnostic spectrum of reactive lymph node changes].

Authors:  S Hartmann; S Kriener; M L Hansmann
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

Review 4.  The normal Langerhans cell and the LCH cell.

Authors:  T Chu; R Jaffe
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 5.  The histopathology of Langerhans cell histiocytosis.

Authors:  B E Favara; R Jaffe
Journal:  Br J Cancer Suppl       Date:  1994-09

Review 6.  Langerhans cell histiocytosis (histiocytosis X).

Authors:  K Y Lam
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

7.  Expression of the monoclonal antibody HECA-452 defined E-selectin ligands in Langerhans cell histiocytosis.

Authors:  I Simonitsch; C W Kopp; I Mosberger; B Volc-Platzer; T Radaszkiewicz
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 8.  Histiocytoses.

Authors:  J L Stéphan
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

9.  Multidetector CT findings of calvarial eosinophilic granuloma.

Authors:  Mehmet Fatih Inci; Rahime Inci; Fuat Ozkan
Journal:  BMJ Case Rep       Date:  2013-05-22

10.  Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America.

Authors:  Natália Rocha Bedran; Román Carlos; Bruno Augusto Benevenuto de Andrade; Ana Paula Silva Bueno; Mário José Romañach; Cristiane Bedran Milito
Journal:  Head Neck Pathol       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.